1. Home
  2. EYE vs RCUS Comparison

EYE vs RCUS Comparison

Compare EYE & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYE
  • RCUS
  • Stock Information
  • Founded
  • EYE 1990
  • RCUS 2015
  • Country
  • EYE United States
  • RCUS United States
  • Employees
  • EYE N/A
  • RCUS N/A
  • Industry
  • EYE Ophthalmic Goods
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EYE Health Care
  • RCUS Health Care
  • Exchange
  • EYE Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • EYE 1.0B
  • RCUS 1.2B
  • IPO Year
  • EYE 2017
  • RCUS 2018
  • Fundamental
  • Price
  • EYE $12.82
  • RCUS $8.17
  • Analyst Decision
  • EYE Hold
  • RCUS Strong Buy
  • Analyst Count
  • EYE 6
  • RCUS 10
  • Target Price
  • EYE $14.00
  • RCUS $29.50
  • AVG Volume (30 Days)
  • EYE 1.6M
  • RCUS 907.7K
  • Earning Date
  • EYE 05-07-2025
  • RCUS 05-07-2025
  • Dividend Yield
  • EYE N/A
  • RCUS N/A
  • EPS Growth
  • EYE N/A
  • RCUS N/A
  • EPS
  • EYE N/A
  • RCUS N/A
  • Revenue
  • EYE $1,823,320,000.00
  • RCUS $258,000,000.00
  • Revenue This Year
  • EYE $5.85
  • RCUS N/A
  • Revenue Next Year
  • EYE $2.80
  • RCUS $28.07
  • P/E Ratio
  • EYE N/A
  • RCUS N/A
  • Revenue Growth
  • EYE 3.81
  • RCUS 120.51
  • 52 Week Low
  • EYE $9.56
  • RCUS $8.02
  • 52 Week High
  • EYE $22.18
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • EYE 54.71
  • RCUS 30.17
  • Support Level
  • EYE $11.53
  • RCUS $8.02
  • Resistance Level
  • EYE $13.72
  • RCUS $9.19
  • Average True Range (ATR)
  • EYE 0.57
  • RCUS 0.46
  • MACD
  • EYE 0.07
  • RCUS 0.01
  • Stochastic Oscillator
  • EYE 61.62
  • RCUS 7.46

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: